{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:14:26Z","timestamp":1787314466858,"version":"build-2736575974"},"reference-count":28,"publisher":"Georg Thieme Verlag KG","issue":"02","funder":[{"name":"Women's Reproductive Health Research","award":["K12HD085816"],"award-info":[{"award-number":["K12HD085816"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Perinatol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study aimed to evaluate trends in the frequency of pharmacologic prophylaxis following the implementation of a postpartum venous thromboembolism (VTE) prevention protocol. Secondarily, to evaluate the association between protocol implementation and incidence of VTE and complications.<\/jats:p>\n                  <jats:p>Retrospective cohort of patients delivering from 2015 to 2022 at a single academic institution. Those with an antepartum VTE or receiving therapeutic anticoagulation were excluded. An inpatient thromboprophylaxis protocol was implemented in January 2017 and further updated in July 2020 to expand risk factors to qualify for prophylaxis and extend the length of therapy to the outpatient setting (total 14 days). The cohort was divided into three time periods: preimplementation (January 1, 2025\u2013December 31, 2016), initial protocol (January 1, 2017\u2013June 30, 2020), and updated (July 1, 2020\u2013December 31, 2022) protocol. The primary outcome was the receipt of inpatient heparin-based pharmacologic prophylaxis. Secondary outcomes included filling an outpatient pharmacologic prophylaxis prescription, VTE, and wound complications observed through 6 weeks postpartum. Baseline characteristics and outcomes were compared across the three protocol periods. Logistic regression modeling estimated the association between outcomes and the updated protocol period compared with prior periods.<\/jats:p>\n                  <jats:p>Overall, 22.6% (95% confidence interval [CI]: 22.1\u201323.0) of 34,217 included deliveries received inpatient pharmacologic prophylaxis: 7.7% (7.1\u20138.2%) preimplementation, 15.8% (15.2\u201316.4%) initial protocol, and 41.2% (40.4\u201342.1%) during the updated protocol period. The rates of inpatient and outpatient prophylaxis increased significantly over time (p\u2009&lt;\u20090.001 test of trend). Delivery in the updated protocol period was not associated with differences in VTE (pre: 0.1%, initial: 0.2%, and updated: 0.1%) nor wound complications (pre: 3.4%, initial: 2.7%, and updated: 2.7%).<\/jats:p>\n                  <jats:p>Single-center implementation of a postpartum prophylaxis protocol resulted in increased use of inpatient and outpatient pharmacologic prophylaxis without changes in rates of VTE or wound complications.<\/jats:p>","DOI":"10.1055\/a-2597-8735","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:41:42Z","timestamp":1746124902000},"page":"164-171","source":"Crossref","is-referenced-by-count":2,"title":["Single Center Implementation of a Postpartum Pharmacologic Thromboprophylaxis Protocol"],"prefix":"10.1055","volume":"43","author":[{"given":"Ann M.","family":"Bruno","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda A.","family":"Allshouse","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Warrick","sequence":"additional","affiliation":[{"name":"Division of Obstetric Anesthesia, Department of Anesthesiology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torr D.","family":"Metz","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"36.e1","DOI":"10.1016\/j.ajog.2008.03.007","article-title":"Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery","volume":"199","author":"S L Clark","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1097\/AOG.0000000000000230","article-title":"Postpartum venous thromboembolism: incidence and risk factors","volume":"123","author":"N K Tepper","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.0007-1323.2001.01800.x","article-title":"Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery","volume":"88","author":"P Mismetti","year":"2001","journal-title":"Br J Surg"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/AOG.0000000000005122","article-title":"Efficacy of postpartum pharmacologic thromboprophylaxis: a systematic review and meta-analysis","volume":"141","author":"M C Oakes","year":"2023","journal-title":"Obstet Gynecol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/AOG.0000000000004521","article-title":"Evaluation of a risk-stratified, heparin-based, obstetric thromboprophylaxis protocol","volume":"138","author":"M Y Lu","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/AOG.0b013e3182029180","article-title":"Rate of wound complications with enoxaparin use among women at high risk for postpartum thrombosis","volume":"117","author":"M A Ferres","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"128.e1","DOI":"10.1016\/j.ajog.2023.11.013","article-title":"Postpartum pharmacologic thromboprophylaxis and complications in a US cohort","volume":"231","author":"A M Bruno","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002706","article-title":"ACOG practice bulletin no. 196: thromboembolism in pregnancy","volume":"132","author":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"B11","DOI":"10.1016\/j.ajog.2020.04.032","article-title":"Society for Maternal-Fetal Medicine Consult Series #51: thromboembolism prophylaxis for cesarean delivery","volume":"223","author":"L D Pacheco","year":"2020","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/AOG.0000000000001579","article-title":"National partnership for maternal safety: consensus bundle on venous thromboembolism","volume":"128","author":"M E D\u02bcAlton","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"13","key":"ref11","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1111\/1471-0528.13706","article-title":"A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines","volume":"123","author":"K L Palmerola","year":"2016","journal-title":"BJOG"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jth.15166","article-title":"Estimating the risk thresholds used by guidelines to recommend postpartum thromboprophylaxis","volume":"19","author":"N Gassmann","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chest.2016.05.021","article-title":"Risks of venous thromboembolism after cesarean sections: a meta-analysis","volume":"150","author":"M Blondon","year":"2016","journal-title":"Chest"},{"issue":"S 02","key":"ref14","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"141","author":"S M Bates","year":"2012","journal-title":"Chest"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1213\/ANE.0000000000002530","article-title":"The Society for Obstetric Anesthesia and Perinatology Consensus Statement on the anesthetic management of pregnant and postpartum women receiving thromboprophylaxis or higher dose anticoagulants","volume":"126","author":"L Leffert","year":"2018","journal-title":"Anesth Analg"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"I A Greer","year":"2005","journal-title":"Blood"},{"issue":"22","key":"ref17","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"S M Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"9596","key":"ref18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"E von Elm","year":"2007","journal-title":"Lancet"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/AOG.0000000000002050","article-title":"Implementation of a risk-based heparin protocol for postpartum venous thromboembolism prevention","volume":"130","author":"E Robison","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/jth.15218","article-title":"Venous thromboembolism incidence among patients recommended for pharmacologic thromboembolism prophylaxis after cesarean delivery in selected guidelines","volume":"19","author":"J J Federspiel","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/AOG.0000000000000007","article-title":"Underuse of postcesarean thromboembolism prophylaxis","volume":"122","author":"A M Friedman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"221.e1","DOI":"10.1016\/j.ajog.2014.09.017","article-title":"Thromboembolism incidence and prophylaxis during vaginal delivery hospitalizations","volume":"212","author":"A M Friedman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"100620","DOI":"10.1016\/j.ajogmf.2022.100620","article-title":"Trends in postpartum venous thromboembolism and chemical prophylaxis among insured US patients","volume":"4","author":"A M Bruno","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref24","volume-title":"Thrombosis and embolism during pregnancy and the puerperium, reducing the risk. Green-top Guideline No. 37a","author":"RCOG","year":"2015"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"i6253","DOI":"10.1136\/bmj.i6253","article-title":"Development and validation of risk prediction model for venous thromboembolism in postpartum women: multinational cohort study","volume":"355","author":"A A Sultan","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.jtha.2024.06.019","article-title":"Preferences of pregnant women for postpartum thromboprophylaxis: the bicentric PREFER-postpartum study","volume":"22","author":"M Blondon","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jama.2024.8684","article-title":"A more selective vs a standard risk-stratified, heparin-based, obstetric thromboprophylaxis protocol","volume":"332","author":"M L Champion","year":"2024","journal-title":"JAMA"},{"issue":"03","key":"ref28","first-page":"CD001689","article-title":"Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period","volume":"3","author":"P Middleton","year":"2021","journal-title":"Cochrane Database Syst Rev"}],"container-title":["American Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2597-8735.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:40:33Z","timestamp":1767656433000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2597-8735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":28,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2026,1,5]]},"published-print":{"date-parts":[[2026,1]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2597-8735","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0735-1631","1098-8785"],"issn-type":[{"value":"0735-1631","type":"print"},{"value":"1098-8785","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5,1]]},"published":{"date-parts":[[2025,5,1]]}}}